Table of Contents: 1 Executive Summary 2 Market Introduction 2.1 Definition 2.2 Scope of the Study 2.3 Assumptions & Limitations 2.3.1 Assumptions 2.3.2 Limitations 2.4 Market Structure 3 Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 3.5 Forecast Model 4 Market Dynamics 4.1 Overview 4.2 Drivers 4.2.1 Rising Prevalence of Infectious Diseases 4.2.2 Advancements in Molecular Diagnostic Techniques 4.2.3 Rising Prevalence of Different Types of Cancer 4.3 Restraints 4.3.1 Stringent Regulatory Policies 4.4 Opportunities 4.4.1 Entering Developing Economies 4.5 Technology Trends & Assessment 5 Market Factor Analysis 5.1 Value Chain Analysis 5.1.1 R&D and Designing 5.1.2 Good Laboratory Practices 5.1.3 Molecular Diagnostics Testing 5.1.4 Distribution and Sales 5.1.5 Post-Sales Monitoring 5.2 Porter’s Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Buyers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitutes 5.2.5 Intensity of Rivalry 5.3 Investment Opportunities 5.4 Pricing Analysis 6 Global Molecular Diagnostics Market, By Product 6.1 Overview 6.2 Reagents & Kits 6.3 Instruments 6.4 Services & Software 7 Global Molecular Diagnostics Market, By Technique 7.1 Overview 7.2 Polymerase Chain Reaction (PCR) 7.3 Isothermal Amplification 7.4 Hybridization 7.5 Sequencing 7.6 Microarray 7.7 Others 8 Global Molecular Diagnostics Market, By Application 8.1 Overview 8.2 Infectious Diseases 8.3 Oncology 8.4 Genetic Tests 8.5 Others 9 Global Molecular Diagnostics Market, By End-User 9.1 Overview 9.2 Hospitals & Clinics 9.3 Diagnostic Laboratories 9.4 Others 10 Global Molecular Diagnostics Market, By Region 10.1 Overview 10.2 Americas 10.2.1 North America 10.2.1.1 US 10.2.1.2 Canada 10.2.2 Latin America 10.3 Europe 10.3.1 Western Europe 10.3.1.1 Germany 10.3.1.2 France 10.3.1.3 UK 10.3.1.4 Italy 10.3.1.5 Spain 10.3.1.6 Rest of Western Europe 10.3.2 Eastern Europe 10.4 Asia-Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 South Korea 10.4.5 Australia 10.4.6 Rest of Asia-Pacific 10.5 Middle East & Africa 10.5.1 Middle East 10.5.2 Africa 11 Competitive Landscape 11.1 Overview 11.2 Company Share Analysis 11.3 Competitive Benchmarking 11.4 Leading Player in Terms of Number of Developments in the Molecular Diagnostics Market 11.5 Key Development Analysis 11.5.1 Partnership/Strategic Agreement 11.5.2 Acquisition 11.5.3 Product Approval 11.5.4 Product Launch 12 Company Profiles 12.1 F. Hoffmann-La Roche Ltd 12.1.1 Company Overview 12.1.2 Financial Overview 12.1.3 Products/Services Offered 12.1.4 Key Developments 12.1.5 SWOT Analysis 12.1.6 Key Strategies 12.2 Hologic, Inc. 12.2.1 Company Overview 12.2.2 Financial Overview 12.2.3 Products/Services Offered 12.2.4 Key Developments 12.2.5 SWOT Analysis 12.2.6 Key Strategies 12.3 Qiagen 12.3.1 Company Overview 12.3.2 Financial Overview 12.3.3 Products/Services Offered 12.3.4 Key Developments 12.3.5 SWOT Analysis 12.3.6 Key Strategies 12.4 Becton, Dickinson, and Company 12.4.1 Company Overview 12.4.2 Financial Overview 12.4.3 Products/Services Offered 12.4.4 Key Developments 12.4.5 SWOT Analysis 12.4.6 Key Strategies 12.5 Abbott Laboratories 12.5.1 Company Overview 12.5.2 Financial Overview 12.5.3 Products/Services Offered 12.5.4 Key Developments 12.5.5 SWOT Analysis 12.5.6 Key Strategies 12.6 Cepheid 12.6.1 Company Overview 12.6.2 Financial Overview 12.6.3 Products/Services Offered 12.6.4 Key Developments 12.6.5 SWOT Analysis 12.6.6 Key Strategies 12.7 Siemens 12.7.1 Company Overview 12.7.2 Financial Overview 12.7.3 Products/Services Offered 12.7.4 Key Developments 12.7.5 SWOT Analysis 12.7.6 Key Strategies 12.8 CLONIT srl 12.8.1 Company Overview 12.8.2 Financial Overview 12.8.3 Products/Services Offered 12.8.4 Key Developments 12.8.5 SWOT Analysis 12.8.6 Key Strategies 12.9 Thermo Fisher Scientific Inc. 12.9.1 Company Overview 12.9.2 Financial Overview 12.9.3 Products Offering 12.9.4 Key Developments 12.9.5 SWOT Analysis 12.9.6 Key Strategies 12.1 Agilent Technologies 12.10.1 Company Overview 12.10.2 Financial Overview 12.10.3 Products/Services Offered 12.10.4 Key Developments 12.10.5 SWOT Analysis 12.10.6 Key Strategies 12.11 EKF Diagnostics 12.11.1 Company Overview 12.11.2 Financial Overview 12.11.3 Products/Services Offered 12.11.4 Key Developments 12.11.5 SWOT Analysis 12.11.6 Key Strategies 12.12 Novartis 12.12.1 Company Overview 12.12.2 Financial Overview 12.12.3 Products/Services Offered 12.12.4 Key Developments 12.12.5 SWOT Analysis 12.12.6 Key Strategies 12.13 Illumina 12.13.1 Company Overview 12.13.2 Financial Overview 12.13.3 Products/Services Offered 12.13.4 Key Developments 12.13.5 SWOT Analysis 12.13.6 Key Strategies 13 Appendix 13.1 References 13.2 Related Reports

List of Tables: TABLE 1 MARKET SYNOPSIS TABLE 2 PRIMARY INTERVIEWS TABLE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR REAGENTS & KITS, BY REGION, 2016–2025 (USD MILLION) TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INSTRUMENTS, BY REGION, 2016–2025 (USD MILLION) TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SERVICES & SOFTWARE, BY REGION, 2016–2025 (USD MILLION) TABLE 7 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2016–2025 (USD MILLION) TABLE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ISOTHERMAL AMPLIFICATION, BY REGION, 2016–2025 (USD MILLION) TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HYBRIDIZATION, BY REGION, 2016–2025 (USD MILLION) TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR SEQUENCING, BY REGION, 2016–2025 (USD MILLION) TABLE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR MICROARRAY, BY REGION, 2016–2025 (USD MILLION) TABLE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016–2025 (USD MILLION) TABLE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2016–2025 (USD MILLION) TABLE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR ONCOLOGY, BY REGION, 2016–2025 (USD MILLION) TABLE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR GENETIC TESTS, BY REGION, 2016–2025 (USD MILLION) TABLE 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016–2025 (USD MILLION) TABLE 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 20 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2016–2025 (USD MILLION) TABLE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2016–2025 (USD MILLION) TABLE 22 GLOBAL MOLECULAR DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2016–2025 (USD MILLION) TABLE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION) TABLE 24 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION) TABLE 25 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 26 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 27 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 28 AMERICAS: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 30 NORTH AMERICA: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%) TABLE 31 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 32 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 33 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 34 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 35 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 36 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 37 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 38 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 39 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 40 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 41 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 42 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 43 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 44 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 46 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 47 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION) TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 49 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 50 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 51 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 52 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 53 WESTERN EUROPE: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%) TABLE 54 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 55 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 56 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 57 WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 58 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 59 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 60 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 61 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 62 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 63 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 64 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 65 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 66 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 67 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 68 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 69 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 70 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 71 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 72 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 73 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 74 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 75 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 76 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 77 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 78 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 79 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 80 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 81 REST OF WESTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 82 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 83 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 84 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 85 EASTERN EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 86 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 87 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018 (%) TABLE 88 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 89 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 90 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 91 ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 92 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 93 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 94 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 95 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 96 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 97 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 98 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 99 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 100 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 101 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 102 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 103 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 104 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 105 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 106 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 107 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 108 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 109 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 110 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 111 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 112 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 113 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 114 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 115 REST OF ASIA-PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 116 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2025 (USD MILLION) TABLE 117 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 118 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 119 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 120 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 121 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 122 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 123 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 124 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 125 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2016–2025 (USD MILLION) TABLE 126 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2016–2025 (USD MILLION) TABLE 127 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2025 (USD MILLION) TABLE 128 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2025 (USD MILLION) TABLE 129 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MOLECULAR DIAGNOSTICS MARKET TABLE 130 PARTNERSHIP/STRATEGIC AGREEMENT TABLE 131 ACQUISITION TABLE 132 MERGER & ACQUISITION TABLE 133 PRODUCT LAUNCHList of Figures: FIGURE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET: MARKET STRUCTURE FIGURE 2 RESEARCH PROCESS FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH FIGURE 4 DRIVERS: IMPACT ANALYSIS FIGURE 5 RESTRAINTS: IMPACT ANALYSIS FIGURE 6 VALUE CHAIN: GLOBAL MOLECULAR DIAGNOSTICS MARKET FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MOLECULAR DIAGNOSTICS MARKET FIGURE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY PRODUCT, 2018 (%) FIGURE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2018 & 2025 (USD MILLION) FIGURE 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY TECHNIQUE, 2018 (%) FIGURE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2018 & 2025 (USD MILLION) FIGURE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2018 (%) FIGURE 13 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018 & 2025 (USD MILLION) FIGURE 14 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY END USER, 2018 (%) FIGURE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018 & 2025 (USD MILLION) FIGURE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%) FIGURE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2018 & 2025 (USD MILLION) FIGURE 18 AMERICAS: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%) FIGURE 19 EUROPE: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%) FIGURE 20 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET SHARE, BY REGION, 2018 (%) FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS 2018 (%) FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS FIGURE 23 MOLECULAR DIAGNOSTICS MARKET, COMPETITIVE LANDSCAPE (% SHARE)

Hologic, Inc.; QIAGEN; Becton, Dickinson and Company; Abbott Laboratories; Cepheid; F. Hoffmann-La Roche Ltd Thermo Fisher Scientific; Agilent Technologies and Siemens